Data may be out of date. Our scheduled checks are behind: the last successful check of the sources finished 20 Oct 2026, 21:00 UTC (12 days ago), more than 36 hours ago. Checks normally run twice daily, so figures on this page may be out of date. See the service status.
ShortageSignal

← All medicines

Medicine · bench card

Co-Codamol

As of 01 Nov 2026 23:45 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.

Latest England noticeMSN/2026/001 Tier 3 · issued 12 Jan 2026 (293 days ago)
Expected backearly June 2026 as stated in the latest recorded notice stated date passed — no update recorded (144 days)window end 10 Jun 2026, derived from “early June 2026”
Protocolno Serious Shortage Protocol matched to this name on the NHSBSA register
ScotlandMSAN(2026)3 issued 14 Jan 2026 — NHS Scotland's own notice, matched by name; kept separate from England

Presentations, as stated in the latest recorded notice

Each line is re-expressed from MSN/2026/001 (12 Jan 2026): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.

PresentationStatus, as statedExpected back, as statedStated in
Co-codamol 30mg/500mg tabletsaffected product · inferred from phrasingLimited supply, as statedearly June 2026precision: early in the month · window end 10 Jun 2026, derived from “early June 2026”notice of 12 Jan 2026
Paracetamol 500mg tabletsnamed by the source as remaining available · inferred from phrasing · its own page →Stated as available— not stated for this linenotice of 12 Jan 2026
Codeine 30mg tabletsnamed by the source as remaining available · inferred from phrasingStated as available; can support only a partial uplift— not stated for this linenotice of 12 Jan 2026
Co-codamol 30mg/500mg capsulesnamed by the source as remaining available · inferred from phrasingStated as available; can support only a partial uplift— not stated for this linenotice of 12 Jan 2026
Co-codamol 30mg/500mg effervescent tabletsnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 12 Jan 2026
Other strengths and forms of co-codamolclass-level statement by the source, not a named product · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 12 Jan 2026
Co-dydramol 30mg/500mg and 20mg/500mg tabletsnamed by the source as remaining available · inferred from phrasingStated as available; cannot support an uplift in demand— not stated for this linenotice of 12 Jan 2026

Protocol in force

No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.

Named in the source as remaining available

  • Paracetamol 500mg tablets — named by the source as remaining available (inferred from phrasing)
  • Codeine 30mg tablets — named by the source as remaining available (inferred from phrasing)
  • Co-codamol 30mg/500mg capsules — named by the source as remaining available (inferred from phrasing)
  • Co-codamol 30mg/500mg effervescent tablets — named by the source as remaining available (inferred from phrasing)
  • Co-dydramol 30mg/500mg and 20mg/500mg tablets — named by the source as remaining available (inferred from phrasing)

Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.

Identifiers — Co-Codamol

Also known as
Co-codamol 12.8mg/500mg tablets · Co-codamol 15mg/500mg capsules · Co-codamol 15mg/500mg effervescent tablets sugar free · Co-codamol 15mg/500mg tablets · Co-codamol 30mg/500mg capsules · Co-codamol 30mg/500mg effervescent powder sachets sugar free · +11 more
BNF chemical
Co-codamol (Codeine phosphate/paracetamol) 0407010F0 — matched on a generic name
Class
Non-opioid analgesics and compound preparations · Analgesics · Central Nervous System
SNOMED codes
10398111000001105, 10398311000001107, 10822611000001105, 10900011000001100, 11005911000001106 and 185 more
Suppliers named in the NHSBSA dataset
A A H Pharmaceuticals Ltd · AAH Hillcross · Accord-UK Ltd · Actavis UK Ltd · Advanz Pharma · Alliance Healthcare (Distribution) Ltd · +39 more (from the dataset, not from the notices)

BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.

BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

History

One supply notification on record, 12 Jan 2026. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.

IssuedNoticeKindTierReference
12 Jan 2026Medicine Supply Notification: Co-codamol 30mg/500mg tabletsSupply notificationTier 3MSN/2026/001

Also recorded under

No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.

Scotland — separate record

NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.

Last checked
20 Oct 2026 — sources are checked twice daily by scheduled jobs, not continuously
Last source change
19 Oct 2026
Latest notice captured
12 Jul 2026
Sources
Latest notice post ↗https://cpe.org.uk/our-news/medicine-supply-notification-co-codamol-30mg-500mg-tablets · methodology · corrections log

Re-expressed facts with links to the source documents; roles are inferred from phrasing and flagged; fuzzy dates stay fuzzy. Not an official NHS or DHSC service and not clinical advice — in a shortage, follow the guidance issued to your pharmacy or prescriber. Absence of a record is never availability.